Loading provider…
- Featuresarrow_drop_down
- Solutionsarrow_drop_down
Loading provider…
Your Medical Sales Assistants that help you easily find, convert and close your ideal providers
Pediatric Hematology & Oncology Physician in Baltimore, MD
NPI: 1427194661HQ Phone
Get MEREDITH CHUK, M.D. Meredith's Phone Numberphone_androidMobile
Get MEREDITH CHUK, M.D. Meredith's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardMD State Medical License
MD State Medical License
2006 - 2026
PA State Medical License
2004 - 2016
WV State Medical License
2011 - 2014
American Board of Pediatrics
Pediatric Hematology-Oncology
Duke University
MS • clinical research
Until 2009
Johns Hopkins University
Fellowship • Pediatric Hematology/Oncology
2005 - 2008
National Cancer Institute
Fellowship • Pediatric Hematology/Oncology
2005 - 2008
UPMC Medical Education
Residency • Pediatrics
2001 - 2004
Penn State College of Medicine
med.psu.edu
Medical School
Until 2001
Authors: Hazarika, Maitreyee, Chuk, Meredith K, Theoret, Marc R, Mushti, Sirisha, He, Kun, Weis, Shawna L, Putman, Alexander H, Helms, Whitney S, Cao, Xianhua, Li, Hongshan, Zhao, Hong, Zhao, Liang, Welch, Joel, Graham, Laurie, Libeg, Meredith, Sridhara, Rajeshwari, Keegan, Patricia, Pazdur, Richard
Journal: Clin Cancer Res
Publication Date: 2017-01-13
Vandetanib in children and adolescents with multiple endocrine neoplasia type 2B associated medullary thyroid carcinoma.
Authors: Brigitte Widemann, Frank Balis
Publication Date: 2013-06-15
(111)In-octreotide scintigraphy for identification of metastatic medullary thyroid carcinoma in children and adolescents.
Authors: Brigitte Widemann, Frank Balis, Clara Chen
Publication Date: 2011-12-14
Lead Sponsor: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, OTHER: Pharmacological Study, DRUG: Cabozantinib S-malate